Quantify fortifies plans for expansion with two Board appointments
Quantify Technology Holdings Limited (ASX:QFY) has announced a Board restructure as part of its broader plan to reposition itself in the intelligent buildings market.
Marking its entry into a new phase of opportunity and growth, QFY has engaged two new independent directors to bolster its expertise as it looks to broaden its global footprint in the holistic intelligent buildings market — in particular, the aged care sector.
Brett Savill brings 25 years of experience across strategy, innovation, regulation, business development and start-ups — with a particular focus on growth and acquisition.
Currently based in Sydney, Savill has held senior operational roles in Australia as well as being a former PricewaterhouseCoopers Partner in the UK. He has worked, or advised, on more than 30 M&A transactions and is an experienced Non-Executive Director.
The second appointee — who will be serving as interim Chairperson — is Lee Christensen, B.Juris., LLB, B. Comm., a commercial lawyer and former Senior Partner of Gadens with over 20 years of experience.
Based in Western Australia, Christensen brings extensive experience in the areas of banking and finance, commercial and corporate law, with a focus on guidance and advice to listed companies on issues of meeting procedure and corporate governance.
Alongside these major changes to QFY’s Board, the company is considering further appointments, and is progressing in its interview process for potential candidates with extensive business experience.
It is expected that a further appointment, specifically that of independent Director and Chairperson, will be announced in the next fortnight.
As part of the restructure, Aidan Montague has resigned as an executive director, effective immediately, to pursue other interests.
QFY remains an early stage play and as such any investment decision should be made with caution and professional financial advice should be sought.
QFY branches into global aged care market
QFY’s Board changes follow close behind the news out of the company earlier this month, that it had signed an agreement with the US-based Electronic Caregiver LLC (ECL) for the development, sales, marketing, and distribution of a collaborative solution for the US and Australian markets.
ECL offers safety and security options for the elderly and chronically ill in an effort to reduce medical complications, extend lifespan, lessen deaths, and support wellness — both through education as well as technology solutions. It gathers and analyses crucial scientific data that relates to risk assessments for the elderly and chronically ill who are either in institutional care or live independently.
QFY has stated it is partnering with ECL to enhance what the company can offer its existing client portfolio, by utilising the specific data collection and control capabilities inherent within QFY’s tech platform.
Short-term positions in small, early stage ASX companies,
with high potential and near term price catalysts.
Focusing on resource exploration, early-stage tech, and biotech.
Exceptional opportunities across a broad range of
early-stage growth sectors with strong management.
Seeking 1,000% plus returns across medium to long-term holds.
Longer-term positions in a variety of sectors.
Seeking strong management where traction is established and have entered into a growth phase.
S3 Consortium Pty Ltd (CAR No.433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information only. Any advice is general advice only. Neither your personal objectives, financial situation nor needs have been taken into consideration. Accordingly you should consider how appropriate the advice (if any) is to those objectives, financial situation and needs, before acting on the advice.
Conflict of Interest Notice
S3 Consortium Pty Ltd does and seeks to do business with companies featured in its articles. As a result, investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of this article. Investors should consider this article as only a single factor in making any investment decision. The publishers of this article also wish to disclose that they may hold this stock in their portfolios and that any decision to purchase this stock should be done so after the purchaser has made their own inquires as to the validity of any information in this article.
The information contained in this article is current at the finalised date. The information contained in this article is based on sources reasonably considered to be reliable by S3 Consortium Pty Ltd, and available in the public domain. No “insider information” is ever sourced, disclosed or used by S3 Consortium.